Clinical Trials Directory

Trials / Completed

CompletedNCT02872818

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Kayseri Education and Research Hospital · Other Government
Sex
Female
Age
8 Weeks – 10 Weeks
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine apoptotic signaling pathways such as Survivin, Bcl-2, Bax, c-Myc and caspase-9 expression levels in rats model with iatrogenic endometrial hyperplasia after metformin and medroxyprogesterone acetate administration.

Conditions

Interventions

TypeNameDescription
DRUG17β estradiol hemihydrate4mg/kg/day for 20 days
DRUGMetformin50 mg/kg/day last 10 days
DRUGmedroxyprogesterone acetate1mg/kg/day last 10 days

Timeline

Start date
2014-10-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2016-08-19
Last updated
2016-08-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02872818. Inclusion in this directory is not an endorsement.

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia (NCT02872818) · Clinical Trials Directory